pSivida Corp. (Nasdaq: PSDV) announced ILUVIEN® , the first sustained release pharmaceutical product for the treatment of chronic diabetic macular ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE